A clinically relevant selective ERK-pathway inhibitor reverses core deficits in a mouse model of autism.
EBioMedicine
; 91: 104565, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-37088035
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autistic Disorder
/
Autism Spectrum Disorder
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
EBioMedicine
Year:
2023
Document type:
Article
Affiliation country:
Canada